Real-life experience with fampridine (Fampyra®) for patients with multiple sclerosis and gait disorders

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial

(2015) Raymond Hupperts et al.   Multiple Sclerosis Journal

Loss of mobility and the patient burden of multiple sclerosis: expert opinion on relevance to daily clinical practice

(2015) Jennifer Smrtka et al.   POSTGRADUATE MEDICINE

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial

(2015) Raymond Hupperts et al.   Multiple Sclerosis Journal

Prolonged-release fampridine improves walking in a proportion of patients with multiple sclerosis

(2013) Henrik K Mathiesen et al.   Expert Review of Neurotherapeutics

Timed 25-Foot Walk: Direct evidence that improving 20% or greater is clinically meaningful in MS

(2013) J. Hobart et al.   NEUROLOGY

4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review

(2013) Henrik Boye Jensen et al.   Therapeutic Advances in Neurological Disorders